The HOTAIR expression is inversely associated with BCR::ABL1 expression in imatinib-treated CML patients, and to PTGS2 showing that CML patients with high BCR::ABL1 expression showed reduced PTGS2 expression. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.